Alba Therapeutics Announces The Presentation Of Results Of A Phase IIa Clinical Trial For...

medicalnewstoday.com     May 22, 2008            

Alba Therapeutics Corporation announced that data from its Phase IIa clinical trial were presented in the Clinical Advances in Celiac Disease session at the Digestive Disease Week (DDW) meeting in San Diego, California. Results of the randomized, double- blind, placebo controlled study of... [read full story]                

Add a comment to the article
Type the code shown